Air Force research review.

Mode of access: Internet.

Air Force airman's guide : Delayed Enlistment Program

Shipping list no.: 86-308-P.

Air Force regulation.

Some no. issued in updated ed.

The limitless sky : Air Force science and technology contributions to the nation /

Shipping list no.: 2005-0086-P.

Air Force Reserve handbook for Congress /

Shipping list no.: 2003-0197-P.

Air Force posture statement.

Latest issue consulted: 2003.

The Air Force chaplain service.

Cover title.

Aim high : Air Force Catholic chaplains, serving the Air Force family.

Mode of access: Internet.

Final environmental impact statement : Air Force, Space Division Housing Project, San Pedro, California.

At head of title on cover: Environmental Impact Analysis Process.

Global reach--global power : Air Force strategic vision, past and future /

"February 1996."

Research interests of the Air Force Office of Scientific Research.

"1 October 1991."

Vulcan's forge : the making of an Air Force Command for weapons acquisition, 1950-1985 /

Includes index.

Air Force federal acquisition regulation supplement (AFFARS).

Loose-leaf for updating by periodic change publications.

Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Mycosis fungoides (MF) and Sezary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin`s lymphomas. Clinical trials in MF/SS have suffered from a lack of standardization in evaluation, staging, assessment, end points, and response criteria. Recently defined criteria for the diagnosis of early MF, guidelines for initial evaluation, and revised staging and classification criteria for MF and SS now offer the potential for uniform staging of patients enrolled in clinical trials for MF/SS. This article presents consensus recommendations for the general conduct of clinical trials of patients with MF/SS as well as methods for standardized assessment of potential disease manifestations in skin, lymph nodes, blood, and visceral organs, and definition of end points and response criteria. These guidelines should facilitate collaboration among investigators and collation of data from sponsor-generated or investigator-initiated clinical trials involving patients with MF or SS. J Clin Oncol 29:2598-2607. (C) 2011 by American Society of Clinical Oncology

The terrestrial air-breathing mollusks of the United States, and the adjacent territories of North America: described and illustrated by Amos Binney. Ed. by Augustus A. Gould ...

4